We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+24.53%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$7.44B
AUM Growth
+$2.18B
Cap. Flow
+$1.12B
Cap. Flow %
15.11%
Top 10 Hldgs %
13.07%
Holding
2,045
New
726
Increased
371
Reduced
415
Closed
520

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$96.8M
2
USB icon
US Bancorp
USB
+$62.4M
3
BNY
Bank of New York Mellon
BNY
+$45.2M
4
META icon
Meta Platforms (Facebook)
META
+$42.3M
5
BAC icon
Bank of America
BAC
+$39.2M

Top Sells

Rank Stock Value
1
CCK icon
Crown Holdings
CCK
+$43.8M
2
JCI icon
Johnson Controls International
JCI
+$43.5M
3
PYPL icon
PayPal
PYPL
+$41.8M
4
PINS icon
Pinterest
PINS
+$32.4M
5
TDY icon
Teledyne Technologies
TDY
+$31.9M

Sector Composition

Rank Sector Weight
1 Financials 19.3%
2 Technology 16.73%
3 Consumer Discretionary 13.16%
4 Industrials 8.74%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAQU
951
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$654K 0.01%
+63,700
New +$654K
XLRN
952
DELISTED
Acceleron Pharma
XLRN
$653K 0.01%
+5,100
New +$598K
VIHAU
953
DELISTED
VPC Impact Acquisition Holdings Unit
VIHAU
$652K 0.01%
60,927
-14,073
-19% -$142K
APSG.U
954
DELISTED
Apollo Strategic Growth Capital Units, each consisting of one Class A Ordinary Share and one-third W
APSG.U
$651K 0.01%
+59,562
New +$609K
BCRX icon
955
BioCryst Pharmaceuticals
BCRX
$2.4B
$650K 0.01%
87,391
-154,020
-64% -$794K
SRPT icon
956
Sarepta Therapeutics
SRPT
$1.79B
$649K 0.01%
3,809
-2,691
-41% -$399K
EYE icon
957
National Vision
EYE
$1.8B
$648K 0.01%
+14,300
New +$622K
MTH icon
958
Meritage Homes
MTH
$4.87B
$646K 0.01%
+15,608
New +$738K
FSM icon
959
Fortuna Silver Mines
FSM
$3.02B
$644K 0.01%
+78,100
New +$541K
RCHGU
960
DELISTED
Recharge Acquisition Corp. Unit
RCHGU
$642K 0.01%
+60,000
New +$605K
BBIO icon
961
BridgeBio Pharma
BBIO
$16.3B
$635K 0.01%
8,926
-14,815
-62% -$715K
CVCO icon
962
Cavco Industries
CVCO
$4.54B
$632K 0.01%
+3,600
New +$668K
HE icon
963
Hawaiian Electric Industries
HE
$2.16B
$630K 0.01%
+17,800
New +$630K
LRN icon
964
Stride
LRN
$3.38B
$630K 0.01%
+29,700
New +$738K
ADV icon
965
Advantage Solutions
ADV
$374M
$629K 0.01%
+1,911
New +$503K
BSN.U
966
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$629K 0.01%
60,000
-34,900
-37% -$353K
JPM icon
967
JPMorgan Chase
JPM
$951B
$626K 0.01%
4,926
+819
+20% +$91.5K
PSN icon
968
Parsons
PSN
$5.09B
$626K 0.01%
17,205
+6,496
+61% +$218K
IEX icon
969
IDEX
IEX
$17.3B
$625K 0.01%
+3,134
New +$596K
IMTX icon
970
Immatics
IMTX
$1.31B
$625K 0.01%
57,875
-400
-0.7% -$4.22K
LHCG
971
DELISTED
LHC Group LLC
LHCG
$619K 0.01%
+2,900
New +$618K
PMVC.U
972
DELISTED
PMV Consumer Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PMVC.U
$618K 0.01%
60,000
-140,000
-70% -$1.41M
OCA.U
973
DELISTED
Omnichannel Acquisition Corp. Units, each consisting of one share of Class A common stock and one-ha
OCA.U
$618K 0.01%
+60,000
New +$612K
EHC icon
974
Encompass Health
EHC
$12.5B
$616K 0.01%
+9,372
New +$551K
GOAC.U
975
DELISTED
GO Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of on
GOAC.U
$615K 0.01%
57,900
-92,100
-61% -$935K
37 38
39
40 41

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Schonfeld Strategic Advisors held 2,045 positions worth $7.44B, up 42% from $5.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.12B of net new capital in Q4 2020, opening 726 new positions and adding to 371 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Crown Holdings, an estimated $43.8M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.
  • Schonfeld Strategic Advisors added most to US Bancorp in Q4 2020, an estimated $62.4M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2020 reduction was Crown Holdings, cutting an estimated $43.8M.
  • Schonfeld Strategic Advisors fully exited Claritev Corp in Q4 2020, selling an estimated $30.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $7.44B portfolio in Q4 2020.
  • Schonfeld Strategic Advisors opened 726 new positions and closed 520 in Q4 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 42% quarter-over-quarter to $7.44B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.